Blog
RSS FeedPosted by Michael Wonder on 03 Jan 2017
TGA rejects Fetzima
3 January 2016 - The TGA rejects the registration dossier for Pierre Fabre's serotonin noradrenaline reuptake inhibitor (SNRI). ...
Posted by Michael Wonder on 22 Dec 2016
TGA approves new lung cancer drug osimertinib for patients dealt cruel double blow
23 December 2016 - Elly Calabia doesn't talk about survival rates and life expectancy with her oncologist. ...
Posted by Michael Wonder on 20 Dec 2016
Productivity Commission’s report recommendations would hurt Australian innovation and delay access to breakthrough medicines
20 December 2016 - The Productivity Commission report recommendations, if adopted, would put local jobs, investment and Australian patients’ early ...
Posted by Michael Wonder on 20 Dec 2016
TGA approves new uses for Janssen's Imbruvica
20 December 2016 - The TGA has approved the use of ibrutinib for first-line use in patients with chronic lymphocytic ...
Posted by Michael Wonder on 07 Dec 2016
Correcting the record: Australia Financial Review story on medicinal cannabis
7 December 2016 - On 5 December 2016, the Australian Financial Review ran a story 'Lambert-backed medicinal cannabis grower leaves for ...
Posted by Michael Wonder on 06 Dec 2016
Antizol approved by TGA
5 December 2016 - The TGA has approved a new medicine from AFT Pharmaceuticals. ...
Posted by Michael Wonder on 05 Dec 2016
World-first clinical trial of cannabis for chemotherapy patients kicks off in NSW
5 December 2016 - Lauren Hew knows she'll be fighting cancer until it wins. ...
Posted by Michael Wonder on 05 Dec 2016
Nocdurna approved by TGA
5 December 2016 - The TGA has approved a new indication for Ferring's desmopressin acetate. ...
Posted by Michael Wonder on 05 Dec 2016
TGA approves AbbVie's Technivie
5 December 2016 - The TGA has approved another AbbVie combination product for use by patients with chronic hepatitis C ...
Posted by Michael Wonder on 02 Dec 2016
Legislation will improve access to medicines and cut red-tape
2 December 2016 - Legislation introduced to Parliament on final sitting day of 2016 will enable faster access to certain ...
Posted by Michael Wonder on 29 Nov 2016
TGA business plan 2016-17
29 November 2016 - The TGA Business Plan 2016-17 provides an overview of our strategic considerations including: ...
Posted by Michael Wonder on 29 Nov 2016
TGA publishes AusPAR for Spiriva Respimat
29 November 2015 - AusPAR published 18 months after registration. ...
Posted by Michael Wonder on 28 Nov 2016
Updating medicine ingredient names
28 November 2016 - The TGA is updating some medicine ingredient names used in Australia to align with names used ...
Posted by Michael Wonder on 28 Nov 2016
AusPARs: questions & answers
28 November 2016 - The TGA provides transparency of the prescription medicines registration process via the online publication of Australian Public ...
Posted by Michael Wonder on 24 Nov 2016
Proposed cap on the R&D tax incentive will hamper clinical trials
22 November 2016 - The proposed $2 million cap on the R&D tax incentive will seriously damage clinical trials activity ...